Breaking News
Sort by:
Top Post
ProPharma Acquires UK Based Digital Lab Consulting
ProPharma Group (ProPharma) the leading global provider of regulatory, clinical, and quality services for the […]
Wellbeing Subsidiary KGK Science Awarded Cannabis Research License from Health Canada
Wellbeing Digital Sciences, an evidence-based mental healthcare company focused on the development and implementation of […]
AppliedVR Awarded Contract with VHA Innovation Ecosystem, a division of the United States Department of Veterans Affairs
AppliedVR, an immersive therapeutics (ITx) pioneer advancing a novel, virtual reality-based approach to medicine, has […]
Horizon Therapeutics Announces First Subject Dosed in Phase 1 Trial Evaluating HZN-457 for the Treatment of Gout
Horizon Therapeutics has announced the first subject has been dosed in a Phase 1 randomized, […]
CDR-Life Announces the Appointment of Nicole Onetto, MD, MSc, to Board of Directors
CDR-Life, a biotechnology company pioneering a new and differentiated class of highly tumor-selective immuno-oncology therapeutics […]
Dantari Debuts with $47 Million Series A to Advance Best-in-Class Targeted Medicines for Solid Tumors
Dantari, a clinical-stage biotechnology company developing best-in-class targeted therapeutics for the treatment of cancers and […]
Abiogen Pharma Acquires German Pharmaceutical Company, Altamedics
Abiogen Pharma has completed the acquisition of the German pharmaceutical distribution company Altamedics GmbH which […]
Generate Biomedicines Demonstrates a Novel Method of Reducing Immunogenicity through Protein Re-surfacing
Generate Biomedicines has announced that it has published data in the peer-reviewed journal Frontiers in […]
Tomorrow Health Fully Automates Order Lifecycle For Full Spectrum Of Durable Medical Equipment
Tomorrow Health, a healthcare technology company enabling more efficient and reliable home-based care, has announced […]
Hansa Biopharma Announces Reimbursement in Italy for Idefirix as Desensitization Treatment for Highly Sensitized Patients in Kidney Transplantation
Hansa Biopharma, a pioneer in enzyme technology for rare immunological conditions, has announced that the […]
BRIM Biotechnology Receives FDA Orphan Drug Designation for BRM424 to Treat Neurotrophic Keratitis
BRIM Biotechnology is pleased to announce that the US Food and Drug Administration (FDA) has […]
- MedRhythms Feasibility Study Shows Positive Topline Results in Parkinson’s Disease Read more
- Ionis receives FDA Fast Track designation for Olezarsen in patients with Familial Chylomicronemia Syndrome Read more
- Sensorion and EVEON Collaborating to Develop an Injection System for the Delivery of Gene Therapy Treatments Into the Inner Ear Read more
- Qurient Announces Dosing of First Patient in Clinical Study for the Treatment of Patients with Solid Tumors Read more
- Marinus Pharmaceuticals Appoints Christine Silverstein to its Board of Directors Read more